[The clinical value of diagnostic-driven therapy of invasive fungal disease (IFD) type unclassified CⅡgroup in multiple myeloma patients during inducing chemotherapy].
作者信息
Chen M L, Li J, Huang B H, Liu J R, Kuang L F, Yuan S W
机构信息
The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2018 May 14;39(5):435-437. doi: 10.3760/cma.j.issn.0253-2727.2018.05.019.
Abstract
摘要
相似文献
1
[The clinical value of diagnostic-driven therapy of invasive fungal disease (IFD) type unclassified CⅡgroup in multiple myeloma patients during inducing chemotherapy].[诊断驱动治疗未分类CⅡ组侵袭性真菌病（IFD）在多发性骨髓瘤患者诱导化疗期间的临床价值]
Zhonghua Xue Ye Xue Za Zhi. 2018 May 14;39(5):435-437. doi: 10.3760/cma.j.issn.0253-2727.2018.05.019.
2
Epidemiology and treatment of invasive fungal diseases in patients with multiple myeloma: findings from a multicenter prospective study from China.多发性骨髓瘤患者侵袭性真菌病的流行病学及治疗：一项来自中国的多中心前瞻性研究结果
Tumour Biol. 2016 Jun;37(6):7893-900. doi: 10.1007/s13277-015-4441-8. Epub 2015 Dec 23.
3
[Diagnostic Value of G and GM Tests in Acute Leukemia Patients with Invasive Fungal Disease].[G试验和GM试验在急性白血病合并侵袭性真菌病患者中的诊断价值]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019 Oct;27(5):1678-1681. doi: 10.19746/j.cnki.issn.1009-2137.2019.05.049.
4
Association between CMV and Invasive Fungal Infections After Autologous Stem Cell Transplant in Lymphoproliferative Malignancies: Opportunistic Partnership or Cause-Effect Relationship?CMV 与淋巴增生性恶性肿瘤自体干细胞移植后侵袭性真菌感染的关系：机会性伙伴关系还是因果关系？
Int J Mol Sci. 2019 Mar 19;20(6):1373. doi: 10.3390/ijms20061373.
5
Caspofungin Treatment for Pulmonary Invasive Fungal Disease in Hematology Patients: A Retrospective Study in a Clinical Practice Setting in China.卡泊芬净治疗血液科患者肺部侵袭性真菌病：一项中国临床实践环境下的回顾性研究
Clin Ther. 2017 Sep;39(9):1758-1768. doi: 10.1016/j.clinthera.2017.07.013. Epub 2017 Jul 28.
6
Triggers for driving treatment of at-risk patients with invasive fungal disease.驱动高危侵袭性真菌病患者治疗的触发因素。
J Antimicrob Chemother. 2013 Nov;68 Suppl 3:iii17-iii24. doi: 10.1093/jac/dkt391.
7
Clinical risk score for invasive fungal diseases in patients with hematological malignancies undergoing chemotherapy: China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study.血液恶性肿瘤患者化疗后侵袭性真菌病的临床风险评分：中国血液病患者抗真菌治疗评估（CAESAR）研究。
Front Med. 2019 Jun;13(3):365-377. doi: 10.1007/s11684-018-0641-0. Epub 2019 Jun 11.
8
Incidence and outcome of invasive fungal disease after front-line intensive chemotherapy in patients with acute myeloid leukemia: impact of antifungal prophylaxis.一线强化化疗后急性髓系白血病患者侵袭性真菌感染的发生率和结局：抗真菌预防的影响。
Ann Hematol. 2019 Sep;98(9):2081-2088. doi: 10.1007/s00277-019-03744-5. Epub 2019 Jun 25.
9
[Epidemiology of invasive fungal disease in patients with hematological diseases].[血液系统疾病患者侵袭性真菌病的流行病学]
Zhonghua Yi Xue Za Zhi. 2013 Sep 24;93(36):2876-9.
10
Secondary antifungal prophylaxis in hematological malignancy patients with previous invasive fungal disease: a retrospective analysis.既往有侵袭性真菌病的血液系统恶性肿瘤患者的二线抗真菌预防：一项回顾性分析。
PLoS One. 2014 Dec 22;9(12):e115461. doi: 10.1371/journal.pone.0115461. eCollection 2014.
本文引用的文献
1
Optimizing antifungal choice and administration.优化抗真菌药物的选择和管理。
Curr Med Res Opin. 2013 Apr;29 Suppl 4:13-8. doi: 10.1185/03007995.2012.761135.
2
Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies.血液恶性肿瘤患者侵袭性真菌感染的流行病学和治疗结局。
Int J Hematol. 2012 Dec;96(6):748-57. doi: 10.1007/s12185-012-1210-y. Epub 2012 Oct 31.
3
Renal involvement in multiple myeloma.
Pol Arch Med Wewn. 2012;122(9):443-8.
4
Impact of the revised (2008) EORTC/MSG definitions for invasive fungal disease on the rates of diagnosis of invasive aspergillosis.修订版（2008）EORTC/MSG 侵袭性真菌病定义对侵袭性曲霉菌病诊断率的影响。
Med Mycol. 2012 Jul;50(5):538-42. doi: 10.3109/13693786.2011.630040. Epub 2011 Nov 10.
5
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.念珠菌病管理临床实践指南：美国传染病学会2009年更新版
Clin Infect Dis. 2009 Mar 1;48(5):503-35. doi: 10.1086/596757.
6
An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality.基于早期CT诊断的一线使用卡泊芬净治疗异基因移植受者侵袭性真菌感染的策略：一种死亡率低的有效策略。
Bone Marrow Transplant. 2009 Jul;44(1):51-6. doi: 10.1038/bmt.2008.427. Epub 2009 Jan 12.
7
A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT.一项比较基于聚合酶链反应（PCR）的治疗与经验性使用脂质体两性霉素B治疗异基因造血干细胞移植（allo-SCT）后患者的前瞻性随机对照试验。
Bone Marrow Transplant. 2009 Apr;43(7):553-61. doi: 10.1038/bmt.2008.355. Epub 2008 Dec 15.
8
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.欧洲癌症研究与治疗组织/侵袭性真菌感染合作组和美国国立过敏与传染病研究所真菌病研究组（EORTC/MSG）共识组对侵袭性真菌病的修订定义。
Clin Infect Dis. 2008 Jun 15;46(12):1813-21. doi: 10.1086/588660.
9
Improved survival in multiple myeloma and the impact of novel therapies.多发性骨髓瘤患者生存率的提高及新型疗法的影响
Blood. 2008 Mar 1;111(5):2516-20. doi: 10.1182/blood-2007-10-116129. Epub 2007 Nov 1.
10
Update on the contribution of galactomannan for the diagnosis of invasive aspergillosis.半乳甘露聚糖在侵袭性曲霉病诊断中的作用最新进展。
Mycopathologia. 2007 Apr;163(4):191-202. doi: 10.1007/s11046-007-9010-2. Epub 2007 Apr 5.
Zotero 插件